Molecular epidemiology of methicillin-resistant Staphylococcus aureus in a university hospital in northwestern Spain by Jaime Ariza-Miguel et al.
RESEARCH ARTICLE
IÄãÙÄã®ÊÄ½ M®ÙÊ®Ê½Ê¦ù (2014) 17:149-157
doi:10.2436/20.1501.01.217. ISSN (print): 1139-6709. e-ISSN: 1618-1095
www.im.microbios.org
Molecular epidemiology of methicillin-resistant 
Staphylococcus aureus in a university hospital 
in northwestern Spain
Jaime Ariza-Miguel,1 Marta Hernández,1 Isabel Fernández-Natal,2,3 
David Rodríguez-Lázaro1,4* 
1Institute of Agricultural Technology of Castilla y León, Valladolid, Spain. 2University Hospital of Leon, Leon, Spain.
3Institute of Biomedicine (IBIOMED), University of Leon, Leon, Spain. 
4Microbiology Section, Faculty of Sciences, University of Burgos, Burgos, Spain
 
Received 10 April 2014 · Accepted 30 September 2014
Summary. Continuous monitoring of methicillin-resistant Staphylococcus aureus (MRSA) is necessary to understand the 
clonal evolution of successful lineages. In this study, we identifi ed the MRSA clones circulating in a Spanish hospital during a 
2-year period, assessed their relationship with antimicrobial resistance profi les, and investigated the presence of the emerging 
community-associated and livestock-associated MRSA lineages (CA-MRSA, LA-MRSA). CC5-MRSA-IV isolates were the 
most frequently recovered, which supports the previously reported prevalence of this clone in Spanish hospitals. We observed 
ST125 isolates that harbored specifi c cassette chromosome recombinase (ccr) gene elements of the staphylococcal cassette 
chromosome mec (SCCmec) types IV and VI. That clone, which was fi rst detected only recently, has increased resistance to 
erythromycin. Furthermore, 94% of the infections were caused by non-multiresistant isolates. Neither CA-MRSA nor LA-MRSA 
isolates were observed. These fi ndings, along with related events over the last decade, suggest the establishment of a clonal 
endemic population in the Spanish clinical environment. [Int Microbiol 2014; 17(3):149-157]
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Introduction
Staphylococcus aureus is an opportunistic pathogen that 
causes a wide range of diseases in humans, from mild skin 
infections to life-threatening diseases such as toxic shock syn-
drome, septicemia, endocarditis, and necrotizing pneumonia. 
Methicillin-resistant Staphylococcus aureus (MRSA) was 
fi rst described in 1960, a year after the introduction of methi-
cillin into clinical practice to treat infections caused by peni-
cillin-resistant strains of S. aureus [11]. Methicillin resistance 
is mediated by the presence of the mecA gene, which encodes 
an additional penicillin-binding protein (PBP2a or PBP2′) 
with low affi nity for β-lactam antibiotics [15]. More recently, 
a novel methicillin-resistance determinant, mecALGA251 or 
mecC, has been described that has 70% homology at the DNA 
level with mecA [9]. Those genes are harbored in a highly di-
verse mobile genetic element, the staphylococcal cassette 
chromosome mec (SCCmec), whose transmission to ecologi-
cally successful methicillin-susceptible S. aureus strains 
(MSSA) led to the emergence of the ancestral MRSA lineages 
[12]. Up to 11 SCCmec types, defi ned by combining the ge-
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netic structures of the cassette chromosome recombinase 
(ccr) gene complex and the mec gene complex, have been de-
scribed [www.sccmec.org/Pages/SCC_TypesEN.html]. Thus, 
MRSA isolates are represented not only by their genetic back-
grounds, but also by the genetic structure of their SCCmec 
elements [8].
MRSA lineages have become a truly global health concern 
over the last few decades, as their worldwide spread has oc-
curred very quickly. The prevalence of MRSA greatly varies 
among countries, provinces and hospitals but it has increased 
signifi cantly since its appearance in 1960. In the USA, MRSA 
infections increased from 4% in the 1980s to 50% of all 
S. aureus infections in the late 1990s [24]. In Spain, MRSA 
infections increased from 1.5% in 1986 to 31.2% in 2002 
[34]. In the worst cases, such as in Taiwan, in 2007 MRSA 
accounted for 80% of all S. aureus isolates causing nosoco-
mial infections [36]. However, the scenario has become even 
more complex. Until the mid 1990s the presence of MRSA 
was restricted to the clinical environment (hospital-acquired 
MRSA, HA-MRSA), but since then MRSA strains have been 
recovered increasingly from the community (community-ac-
quired MRSA, CA-MRSA) [33]. In contrast to HA-MRSA, 
CA-MRSA strains are frequently isolated from children and 
young people without previous health-care contact and they 
show specifi c genetic and phenotypic traits: they have a dif-
ferent genetic background, harbor a smaller SCCmec type IV 
or V, which provides them with a selective advantage in terms 
of faster replication times, present more virulence mediated 
by factors such as the Panton-Valentine leukocidin cytotoxin 
(PVL), and usually have a non-multiresistant antimicrobial 
profi le [26]. 
The recurrent penetration of CA-MRSA into the clinical 
environment has blurred the boundary between HA-MRSA 
and CA-MRSA, making it more diffi cult to discriminate be-
tween them. In addition, a livestock-associated MRSA (LA-
MRSA) has been described. LA-MRSA strains may act as 
genetic reservoirs of resistance and could play a major role in 
the adaptive evolution of MRSA. In fact, the recently de-
scribed methicillin resistance gene mecC was originally de-
tected in LA-MRSA strains but is now increasingly recovered 
from clinical settings [9,27]. Continuous molecular epidemio-
logic surveillance of MRSA is imperative to trace the evolu-
tion and spread of successful MRSA clones, both for thera-
peutic reasons and for the implementation of initiatives aimed 
at controlling and preventing MRSA infections. Here we de-
scribe a molecular epidemiology study of MRSA isolates re-
covered from the University Hospital of Leon from 2007 to 
2008. The genetic backgrounds of these isolates were charac-
terized by pulsed-fi eld gel electrophoresis (PFGE) and multi-
locus sequence typing (MLST), and the structures of the re-
spective SCCmec elements were determined. Furthermore, 
we investigated both the antimicrobial resistance profi les of 
CA-MRSA and the presence of their PVL genes, as markers. 
By identifi ying the MRSA clones circulating in the hospital, 
this study contributes to the knowledge of the MRSA lineages 
circulating in Spanish health-care setting.
Materials and methods
Clinical information and bacterial isolates. Seventy Staphylo-
coccus aureus isolates recovered from patients at the University Hospital of 
Leon (Leon, northwestrn Spain), between 2007 and 2008 were determined to 
be MRSA based on antimicrobial susceptibility testing. The University Hospi-
tal of Leon is a 795-bed public teaching hospital. Forty-nine isolates were re-
covered from blood cultures (one of them was recovered also from bile); 14 
from central venous catheter blood samples; 3 from peripheral vascular cath-
eter blood samples; 1 from packed red blood cells; 1 from a drainage sample; 
1 from synovial joint fl uid; and 1 from ascites. The specimens were isolated 
and identifi ed in conventional medium (mannitol salt agar, blood and choco-
late agar plates) and commercial MicroScan microdilution panels (Siemens 
Diagnostics, Munich, Germany) and by real-time PCR [32] in a 7500 real-
time PCR system platform (Applied Biosystems, Carlsbad, CA, USA). Meth-
icillin resistance was confi rmed in 68 of the 70 isolates by using internal am-
plifi cation controls designed within the mecA gene [13,22]. Isolates SA13 and 
SA65, which were MRSA as revealed by antimicrobial susceptibility testing, 
tested negative for the presence of mecA. Repetition of the susceptibility tests 
confi rmed both isolates as MSSA.
Antimicrobial susceptibility testing. Antimicrobial susceptibility 
testing was performed by the microdilution method following the recommen-
dations and minimal inhibitory concentration (MIC) breakpoints of the Clini-
cal and Laboratory Standars Institute (CLSI) guidelines (2008). Susceptibility 
to the following 15 antimicrobial agents was tested: ampicillin, penicillin, 
oxacillin, amoxicillin/clavulanate, cefotaxime, erythromycin, clindamycin, 
teicoplanin, vancomycin, ciprofl oxacin, imipenem, gentamicin, rifampicin, 
tetracycline, and cotrimoxazole. MRSA isolates were clustered in resistance 
profi les (RPs) according to their susceptibility to 10 antimicrobials: ampicillin, 
penicillin, erythromycin, teicoplanin, vancomycin, ciprofl oxacin, imipenem, 
rifampicin, tetracycline, and cotrimoxazole. Isolates resistant to three or more 
antibiotics, in addition to β-lactams, were considered to be multiresistant.
Characterization of the genetic background. Genetic charac-
terization of all S. aureus isolates was carried out by pulse-fi eld gel electro-
phoresis (PFGE) and multilocus sequence typing (MLST). PFGE was per-
formed following the method McDougal et al. [16] modifi ed as follows: 
bacterial cells were suspended in PIV buffer (10 mM Tris-HCl, 1 M NaCl, pH 
8) to an absorbance of 0.9–1.1 at 610 nm. Then, 200 μl of the adjusted culture 
was washed and resuspended in 300 μl of the same buffer. After the lysis step, 
the plugs were transferred into a new tube containing 1 ml ESP buffer (1% 
N-lauroyl sarcosine in 0.5 M EDTA pH 8, 100 μg proteinase K/ml) and incu-
bated at 56ºC for 16–20 h. DNA fragment sizes were determined by compar-
ing bands with a Lambda Ladder PFG Marker (New England Biolabs). PFGE 
profi les were analyzed using Bionumerics v.6.6 (Applied-Maths NV, Sint-
Martens-Latem, Belgium) to describe genetic relationships among isolates. 
INT. MICROBIOL. Vol. 17, 2014MOLECULAR EPIDEMIOLOGY OF MRSA 151
Dendograms were constructed using the Dice similarity coeffi cient and the 
unweighted pair group mathematical average (UPGMA) clustering algo-
rithm. MLST was carried out as previously described [8]. DNA isolation was 
performed using the commercial kit QIAamp DNA mini kit (QIAGEN, 
Hilden, Germany) following the manufacturer’s instructions. To guarantee 
analysis of identical genetic material by PFGE and MLST, DNA from the 
same culture was used for both methods. Allelic profi les obtained by MLST 
were assigned by comparing the consensus sequences with the information 
already published in the S. aureus MLST database hosted at [http://saureus.
mlst.net/]. Thereby, genotypes were constituted by seven numbers represent-
ing the unique allelic profi les at seven housekeeping genes. Data regarding 
the 70 isolates analyzed, as well as the novel allelic profi les were submitted 
to the MLST database. Allelic profi les were used to compare the S. aureus 
isolates recovered from our hospital with those previously analyzed from 
other geographic areas. Simpson’s index of diversity, which measures the 
probability that two unrelated strains sampled from the test population will be 
placed into different typing groups [10], was calculated to compare the dis-
criminative power of PFGE typing versus MLST and for measuring genetic 
diversity among isolates using the comparing partitions website [http://dar-
win.phyloviz.net/ComparingPartitions/index.php?link=Home]. The adjusted 
Wallace coeffi cient for quantifi cation of the agreement between PFGE typing 
and MLST was calculated on that website.
Typing and subtyping of the SCCmec element. The genetic 
structure of the SCCmec element was determined by multiplex-PCR carried out 
on a Veriti 96 Well thermal cycler and GeneAmp PCR system 9700 (Applied 
Biosystems) as described elsewhere [13,22]. These two molecular methods al-
lowed discrimination of SCCmec types I, II, III, IV, V and VI, as well as the 
variants IA & IIIA. SCCmec IV was further subtyped into eight different sub-
types, from IVa to IVh, by multiplex-PCR as previously described [18].
Detection of Panton-Valentine leukocidin virulence fac-
tors. The presence of the PVL genes (lukS-PV & lukF-PV) was investigated 
by conventional PCR as previously described [14]. Reference strain ATCC 
49775 was used as the positive control.
Results
Antimicrobial susceptibility testing. All 68 MRSA 
isolates were resistant to the β-lactam antibiotics tested (oxa-
cillin, ampicillin, penicillin, cefotaxime and imipenem) as well 
as to amoxicillin/clavulanate and ciprofl oxacin. Furthermore, 
42.6% of the isolates were resistant to erythromycin, 21% 
were resistant to clindamycin, 15.9% were resistant to genta-
micin, 4.4% to rifampicin and 1.5% to both tetracycline and 
cotrimoxazole. Of the isolates resistant to erythromycin, 
34.8% had the M phenotype. All isolates were susceptible to 
the glycopeptide antimicrobial agents vancomycin and teico-
planin. The isolates were clustered into fi ve RPs, with all the 
isolates resistant to the β-lactam antibiotics tested and to at 
least one more antimicrobial agent (Table 1). Notably, the per-
centage of MRSA resistant to gentamicin increased from 5.7% 
in 2007 to 28.6% in 2008. Resistance to erythromycin, rifam-
picin, tetracycline, and cotrimoxazole also increased during 
the study period albeit to a lesser extent, while resistance to 
clindamycin decreased from 23.5% in 2007 to 17.9% in 2008 
(Table 2). 
Genetic background. Genetic characterization of all 70 
S. aureus isolates by PFGE with the restriction enzyme SmaI 
revealed 27 different pulsotypes (25 pulsotypes among the 68 
MRSA isolates), resulting in a Simpson’s index of diversity of 
0.909, which indicated that, if two isolates were sampled ran-
domly from the population, on 90.9% of the occasions they 
would fall into different types. Genotypes 19 and 26 account-
ed for 40% of the isolates (17.1% and 22.9%, respectively). A 
dendrogram constructed using the Dice similarity coeffi cient 
with the UPGMA clustering algorithm revealed four major 
clusters (arbitrarily designated from A to D) with a cutoff of 
90% similarity. More than 81% of the isolates were grouped 
into these four genetic clusters. Genotypes that did not belong 
to these clusters were designed as “sporadic.” Cluster A com-
prised 18 ST5-MRSA-IV isolates, two novel sequence types 
(STs) derived from ST-5, and one ST125-MRSA-IV. Cluster 
B comprised ten ST125-MRSA-IV and one ST5-MRSA-IV. 
 
Table 1. Resistance profi les of 68 methicillin-resistant Staphylococcus aureus isolates at the University Hospital of Leon, 2007 and 2008
Resistance profi le Antimicrobial agenta % MRSA clones
RP0 Only to β-lactams 0 None
RP1 CIP 55.2 ST5-IV(10); ST8-IV(14); ST125-IV(12); ST125-IV/VI(2)
RP2 ERY, CIP 38.8 ST5-IV(10); ST8-IV(1); ST125-IV(4); ST125-IV/VI(8); ST228-I(1); 
ST2755-IV(1); ST2756-IV(1)
RP3 ERY, CIP, RIF 3 ST5-IV(2)
RP4 ERY, CIP, COT 1.5 ST8-IV(1)
RP5 CIP, RIF, TET 1.5 ST5-IV(1)
aAll isolates were resistant to the β-lactam antibiotics tested: oxacillin, ampicillin, penicillin, cefotaxime and imipenem). CIP, ciprofl oxacin; ERY, 
erythromycin; RIF, rifampicin; COT, cotrimoxazole; TET, tetracycline.
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Cluster C grouped nine ST125-MRSA-IV/VI isolates, and 
cluster D all sixteen ST8-MRSA-IV isolates (Fig. 1). 
Overall, among the 68 MRSA isolates, six STs were de-
termined by MLST analysis. Three of the six accounted for 
95.6% of the isolates: ST-125 (38.2%), ST-5 (33.8%), and 
ST-8 (23.5 %). ST-228 and two novel STs were also detected, 
in one isolate each. Detected clones belonged to the clonal 
complexes CC5 (76.5 %) and CC8 (23.5 %). After submission 
to the S. aureus MLST database [http://saureus.mlst.net/], 
novel STs were designated as ST-2755 and ST-2756 (allelic 
profi les 314–4–1–4–12–1–10 and 1–4–1–4–12–1–320 at 
arcC, aroE, glpF, gmk, pta, tpi, and yqiL, respectively). The 
novel STs were very similar to ST-5: ST-2755 had a unique 
difference of a single nucleotide polymorphism (SNP) in nu-
cleotide 39 of arcC, showing 99% similarity with arcC allele 
1. However, this difference at the DNA level was not trans-
lated into the functional level since both codons encoded the 
amino acid threonine. In addition, ST-2756 had a SNP in nu-
cleotide 256 of allele 10 of yqiL (99% similarity), where thy-
mine is replaced by guanine. This change leads to a non syn-
onymous substitution in which cysteine is substituted by gly-
cine in the encoded protein. MSSA isolates SA 13 and SA 65 
belonged to ST-15 and ST-5, respectively. In 2007, the most 
frequently recovered isolates belonged to ST-5 and ST-125 
(38.9% each one), followed by ST-8 (19.4%). ST-2756 was 
recovered just one isolate. In 2008, isolates showing ST-125 
were the most frequently isolated (37.5%), followed by those 
of ST-5 and ST-8 (28.1% each). ST-228 and ST-2755 were 
also sporadically observed in one isolate.
Genetic structure of the SCCmec element. The 
genetic structure of the SCCmec element was investigated in 
all S. aureus isolates. During the 2-year study period, 67 out of 
68 MRSA isolates (98.5%) harbored SCCmec type IV; the 
remaining isolate (SA16) harbored SCCmec type I (1.5%). 
Further subtyping of SCCmec IV revealed that all belonged 
to subtypes IVc/IVe. Note that, 38.5% of the ST125-MRSA-
IV isolates (14.9% of all isolates harboring SCCmec IV) also 
had specifi c ccr gene elements of SCCmec type VI (mecA 
gene complex class B and ccr gene complexes type 2 and 4; 
A2B2 and A4B4, respectively) and consequently were desig-
nated as ST125-MRSA-IV/VI. Furthermore, 37 out of the 67 
(55.2%) SCCmec type IV elements contained an additional 
381-bp DNA fragment according to the system previously 
described by Oliveira and Lencastre [22], corresponding to 
the presence of the kanamycin/neomycin/bleomycin resis-
tance plasmid pUB110. The evolution of the MRSA clones 
circulating at our hospital over the 2-year study period are 
shown in Fig. 2.
Congruence between PFGE-typing and MLST. 
PFGE better discriminated among the 70 S. aureus isolates than 
MLST (Simpson’s index of diversity of 0.909 and. 0.701, respec-
tively). The adjusted Wallace coeffi cient PFGE→MLVA was 
0.883, with a 95% confi dence interval (CI) of 0.765–1.000; the 
coeffi cient for MLVA→PFGE was 0.208 (CI 95%; 0.137–
0.279). These values implied that if two isolates were in the 
same pulsotype, they had an 88.3% chance of having the same 
MLST genotype; conversely, sharing the same MLST type was 
associated with only a 20.8% chance of having the same pulso-
type. Two discordant results (group violations) were obtained 
by PFGE typing. Isolate SA 45, belonging to ST-125, clustered 
closely with isolates showing ST-5. Conversely, isolate SA 29, 
which belonged to ST-5, was clustered in a branch closely re-
lated to other isolates from ST-125 (Fig. 1). The molecular typ-
ing results are summarized in Table 3. 
 
Table 2. Evolution of the resistance to antimicrobials by 68 methicillin-resistant Staphylococcus aureus isolates, University 
Hospital of Leon, 2007 and 2008
Antibioticsa 2007b 2008b ∆(2008–2007)c
Erythromycin 41.7 43.8 +2.1
Clindamicyn 23.5 17.9 –5.6
Gentamycin 5.7 28.6 +22.9
Rifampicin 2.8 6.3 +3.5
Tetracicline 0 3.1 +3.1
Cotrimoxazole 0 3.1 +3.1
aAll MRSA isolates were resistant to the β-lactam antibiotics tested: oxacillin, ampicillin, penicillin, cefotaxime, and imipenem. 
They were also resistant to amoxicillin/clavulanate and ciprofl oxacin, and were susceptible to vancomycin and teicoplanin.
bPercentage of the mean values of antibiotic resistance.
cDifferences between the percentages of the mean values of antibiotic resistance in 2007 and 2008.
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Fig. 1. Genetic relationships among 70 Staphylococcus aureus isolates based upon comparisons of the pulsed-fi eld gel electrophoresis profi les obtained with 
the restriction enzyme SmaI. The dendrogram was produced using a Dice similarity coeffi cient matrix with the unweighted pair group method with arithmetic 
mean (UPGMA). Major clusters with a cutoff of 90 % similarity were arbitrarily designated from A to D. Scale bar indicates similarity values.
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Panton-Valentine leukocidin genes. All 70 S. au-
reus isolates tested negative for the presence of the PVL genes 
(lukS-PV and lukF-PV). Type strain ATCC 49775, included as 
a positive control, gave the expected 433-bp DNA fragment in 
all PCRs.
Discussion
In 2006, MRSA in Spain accounted for 30% of all S. aureus 
clinical isolates [5]. Until 1995, ST247-MRSA-I (classically 
known as the ‘Iberian clone’) had been the most frequently 
observed type in the clinical environment. However, this 
clone has been gradually replaced by others, and nowadays, 
ST5-MRSA-IV and ST125-MRSA-IV are the predominant 
clones in Spanish hospitals [28,34,35]. The results of our 
study are in agreement with that trend: in 2007–2008, the re-
covery rate of MRSA at the University Hospital of Leon 
reached 38.7%. Overall, ST5-MRSA-IV was the most fre-
quently detected clone (33.8%), followed by ST125-MRSA-
IV (23.5%), ST8-MRSA-IV (23.5%), and ST125-MRSA-IV/
VI (14.7%). Moreover, ST228-MRSA-I and two novel STs 
were sporadically recovered, accounting for one isolate each 
(1.5%). ST125 isolates have rarely been recovered world-
wide, according to the S. aureus MLST database [http://sau-
reus.mlst.net]. In fact, only 7 out of the 5024 isolates available 
from that database belong to ST125 (0.14%, on 08/27/2013). 
Four of the isolates occurred in Spain, and the other three in 
Norway, Finland, and France, respectively. The reason for the 
apparent evolutionary success of clone ST125-MRSA-IV in 
Spanish hospitals is unclear, nor is it understood why that 
clone has not spread to other European countries.
Previous studies had reported the gradual replacement in 
the clinical setting of multiresistant SCCmec elements—clas-
sically found in HA-MRSA isolates—by SCCmec IV, which 
was initially detected in CA-MRSA isolates and harbors no 
further resistance elements [17,20,23,28,30,34,35]. The ge-
netic structure of the SCCmec elements analyzed in this study 
supports that fi nding, since 98.5% of the isolates in this study 
harbored SCCmec IV (14.9% of them also harbored specifi c 
ccr gene elements of SCCmec type VI). The successful intro-
duction and persistence of the genetically shorter SCCmec IV 
in clinical settings might have provided MRSA strains with an 
evolutionary advantage in terms of faster replication times, 
allowing them to outcompete the previously prevalent HA-
MRSA clones harboring multiresistant SCCmec types [21]. 
Further subtyping of SCCmec IV revealed that all of them be-
longed to subtype IVc/IVe. Previous nationwide studies report-
ed that around 70% of all MRSA isolates harboring SCCmec IV 
belong to subtype IVa [17,28,35]. However, our fi ndings are in 
agreement with those published by Argudín et al. [2], in which 
88.5% of MRSA isolates carry subtype IVc. Note that the study 
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Fig. 2. Clonal evolution of 68 methicillin-resistant Staphylococcus aureus isolates recovered from 2007 to 2008 at the University Hospital 
of Leon.
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of Argudín et al. was performed in a hospital located in Astur-
ias, the neighbor region of León. Further research is necessary 
to clarify whether, in Spain, there is a correlation between SC-
Cmec types and their geographical origin.
The successful establishment of SCCmec IV in the clinical 
environment has led to a global change in MRSA resistance 
profi les. Many studies have reported the gradual replacement 
of the classical multiresistant HA-MRSA clones by non-mul-
tiresistant isolates harboring SCCmec IV [1,2,6,25,31,33]. 
Accordingly, in this work 94% of MRSA isolates were non-
multiresistant, as they were resistant to only one or two anti-
biotics in addition to β-lactams (RP1 and RP2) (Table 1). This 
scenario is in agreement with the presence of the prevalent 
lineage CC5 harboring SCCmec IV, which carries no further 
resistance elements. Moreover, all the isolates were suscepti-
ble to glycopeptides. The increase in gentamicin resistance—
from 5.7% in 2007 to 28.6% in 2008 (Table 2)—was not as-
sociated with any particular genotype.
The presence of CC5-MRSA strains harboring multiple or 
composite SCCmec elements has been previously reported 
[19]. In this study, we found ST125 isolates that carried specifi c 
ccr gene elements of both SCCmec types IV and VI (38.5% of 
ST125 isolates and 14.9% of all isolates harboring SCCmec 
IV). This clone was recently detected in a third-level hospital 
in Valladolid, a neighbor city of León [17]. Nine out of the ten 
isolates were grouped into cluster C by PFGE, and the re-
maining one yielded a sporadic pulsotype (Fig. 1). The recov-
ery rate of ST125-MRSA-IV/VI increased from 5.6% in 2007 
to 25% in 2008, while the presence of ST125-MRSA-IV de-
creased from 33.3% in 2007 to 12.4% in 2008 (Fig. 2). As 
previously observed by Menegotto et al. [17], in our study, 
80% of ST125-MRSA-IV/VI isolates but just 25% of ST125-
MRSA-IV isolates were resistant to erythromycin (RP2). 
These fi ndings suggest that the clonal replacement observed 
might have occurred because of antibiotic selective pressure.
Two novel STs, designated ST-2755 and ST-2756, were 
detected in this study. Both genotypes were single-locus vari-
ants of ST5 belonging to CC5. ST-2755 had one SNP in nu-
cleotide 39 of allele 1 of arcC, and ST-2756 one SNP in nucle-
otide 256 of allele 10 of yqiL. These STs might have emerged 
as punctual mutations from ST5-MRSA isolates since both 
are single-locus variants of ST5 and, to our knowledge, this 
genotype has not been observed in MSSA strains (or at least 
there are no S. aureus strains with those genotypes in the 
MLST database). Both strains were recovered from blood cul-
ture samples, were RP2, and were grouped by PFGE into 
cluster A, along with ST5 isolates. Moreover, neither CA-
MRSA nor LA-MRSA strains were detected in this study, and 
Table 3. Correlation between the genotyping methods used in 70 Staphylococcus aureus isolates (68 MRSA), at the University of Leon Hospital, 2007 
and 2008
CC(n) ST(n) Allelic profi le PFGE cluster(n) SCCmec type(n) MRSA clone(n)
CC5(54) 5(24) 1-4-1-4-12-1-10 A(18) IV(18) ST5-MRSA-IV(23); ST5-MSSA(1)
B(1) IV(1)
Sporadica(5) IV(4); Noneb(1)
A(1) IV(1)
B(10) IV(10)
125(26) 1-4-1-4-12-1-54 C(9) IV/VI(9) ST125-MRSA-IV(16); ST125-MRSA-IV/VI(10)
Sporadic(6) IV(5); IV/VI(1)
15(1) 13-13-1-1-12-11-13 Sporadic(1) Noneb(1) ST15-MSSA(1)
228(1) 1-4-1-4-12-24-29 Sporadic(1) I(1) ST228-MRSA-I(1)
2755(1)c 314-4-1-4-12-1-10 A(1) IV(1) ST2755-MRSA-IV(1)
2756(1)c 1-4-1-4-12-1-320 A(1) IV(1) ST2756-MRSA-IV(1)
CC8(16) 8(16) 3-3-1-1-4-4-3 D(16) IV(16) ST8-MRSA-IV(16)
CC, clonal complex. ST, sequence type. PFGE, pulse-fi eld gel electrophoresis. SCCmec, staphylococcal cassette chromosome mec. MLST, multilocus 
sequence typing.
aPulsotypes that did not belong to the main clusters were designed as “sporadic.”
bMethicillin-susceptible S. aureus did not harbor a SCCmec element.
cNovel genotype as determined by  MLST.
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all 70 isolates tested negative for the presence of PVL genes. 
According to previous studies carried out in Spanish clinical 
settings, it seems that, despite worldwide emergence of CA-
MRSA strains harboring PVL genes [33], this is still an atypi-
cal situation in Spain and is mainly restricted to the introduc-
tion of exotic strains from South America [3,4,29].
As expected, molecular typing by PFGE provided better 
discrimination than MLST (Simpson’s index of diversity of 
0.909 vs. 0.701, respectively). We observed two group viola-
tions by PFGE (Fig. 1), which has been previously reported 
since these two typing methods index very different types of 
variations. PFGE-typing can detect genomic variations with a 
wide range of causes, and thus identify minor variations 
among isolates collected within a restricted geographic area 
(e.g., in one hospital). However, such rapidly evolving se-
quences are susceptible to homoplasy, which can lead to in-
correct phylogenetic inferences. MLST indexes variations in 
seven housekeeping genes under stabilizing evolution, and is 
therefore more suitable for population studies.
Continuous monitoring of MRSA clones circulating in 
clinical settings is necessary to better understand the clonal 
evolution of successful MRSA lineages and to apply appro-
priate treatment, control, and prevention strategies aimed at 
hindering the dissemination of MRSA infections. Our molec-
ular epidemiology study of MRSA isolates in a Spanish 
health-care institution identifi ed CC5-MRSA-IV strains 
(ST5-MRSA-IV and ST125-MRSA-IV clones) as the most 
frequently recovered strains, which confi rms the previously 
reported prevalence of these clones in the Spanish clinical en-
vironment. 
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